Rtw Investments, LP Alkermes Plc. Transaction History
Rtw Investments, LP
- $6.13 Billion
- Q4 2024
A detailed history of Rtw Investments, LP transactions in Alkermes Plc. stock. As of the latest transaction made, Rtw Investments, LP holds 7,557,835 shares of ALKS stock, worth $251 Million. This represents 3.55% of its overall portfolio holdings.
Number of Shares
7,557,835
Previous 6,654,033
13.58%
Holding current value
$251 Million
Previous $186 Million
16.71%
% of portfolio
3.55%
Previous 2.97%
Shares
6 transactions
Others Institutions Holding ALKS
# of Institutions
375Shares Held
166MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$967 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$614 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$407 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$293 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny5.48MShares$182 Million0.25% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.45B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...